In observational studies elevated levels of CRP, TNFα and suPAR were associated with a poor prognosis in CAD [13–15] suggesting that the decreases in low-grade inflammation obtained in the present study might improve the participants’ prognosis. The gene discussed is TNF; the disease is coronary artery disorder.